Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Epstein Becker Grows Consulting Arm With Two Hires

Feb. 16, 2016, 5:25 PM

In an expansion of its consulting arm, Epstein Becker & Green has added two health care and human resources specialists.

Sam Nussbaum, former executive vice president, and chief medical officer at Anthem, who also has served as a professor and clinical leader at Harvard Medical School and Massachusetts General Hospital, will be based in Washington, D.C.; and Xan Raskin, a former assistant general counsel at Bristol-Myers Squibb will be based in New York. Both joined the firm’s consulting arm, EBG Advisors, in January.

Bob Atlas, president of EBG Advisors Inc., said the company now has a team of 10 in-house consultants from the health care and HR industries, since launching in 2006.

EBG Advisors primarily operates in the health care space, and because health entities are often very large employers who may face workplace issues, it made sense to bring in HR capabilities as well, according to the firm.

Fees for consultant services are either billed on an hourly basis, or more often, are built into a project price, according to Mark Lutes, chairman of EBG.

To explain what the consulting firm does, Lutes gave the example of a client that’s a managed care plan that faces sanctions imposed by an administrative agency. EBG brings in operations’ advisors who show the client how the system that’s in place is producing the behavior that’s causing it to be non-compliant.

He also said the firm also has a “very active” practice on behalf of private equity sponsors who are investing in health care companies. EBG and its consulting group are able to help clients think about due diligence not only from the view of is there a danger of litigation or shutdown from a compliance perspective, he said. But also to look at issues involving coding, how folks who run the hospital systems are interacting with the products and services of the company under evaluation, or how commercial payers are looking at the company in which the client is potentially investing.

“By bringing in through EBG Advisors, folks who have had executive positions in large health care systems and large payers, into our analytics, our clients find there are efficiencies,” Lutes said.